AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 4

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 99.04 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019433L-Glutathione (reduced)HYBHYB-2502-S7614Nordanalyt2025-Q299.478.54—Buyer-sourced0PASS
AX-2025-019334EpitalonAMBAMB-2411-X6617Janoshik2025-Q299.895.64102.7Laboratory-retained0FAIL
AX-2025-019008RetatrutideASYASY-{CAT}-2342Medutest2025-Q299.930.77—Buyer-sourced0PASS
AX-2025-018697TB-500QSCQSC-2504-T6759Janoshik2025-Q299.823.1796.5Buyer-sourced1MARGINAL
AX-2025-021195RetatrutidePPGPPG-2501-B7212Kestrel2025-Q299.863.7993.9Buyer-sourced0PASS
AX-2025-020910SurvodutideWXTWXT-2501-X2463Janoshik2025-Q297.854.32—Buyer-sourced2MARGINAL
AX-2025-020593GHRP-2SSASSA-2505-D7550Medutest2025-Q299.214.29102.9Buyer-sourced0PASS
AX-2025-020421KPVMKMMKM-2504-N4868Medutest2025-Q299.934.4189.0Supplier-supplied1FAIL
AX-2025-020176Kisspeptin-10ERPERP-2504-G9130Janoshik2025-Q298.635.42—Buyer-sourced1MARGINAL
AX-2025-020095TirzepatideSWBSWB-2505-R8575Janoshik2025-Q298.942.3191.6Buyer-sourced2FAIL
AX-2025-019542CJC-1295 (no DAC)TFCTFC-2411-M9928PeptideMeter2025-Q299.072.4988.6Laboratory-retained1MARGINAL
AX-2025-019527EpitalonJEEPJEEP-2502-J8739Janoshik2025-Q299.939.4799.9Buyer-sourced0FAIL
AX-2025-019516GHRP-6JEEPJEEP-2503-B8635Janoshik2025-Q299.234.69101.4Buyer-sourced0PASS
AX-2025-019337EpitalonAMBAMB-2411-X6617VendorInvestigate2025-Q299.936.1296.9Buyer-sourced0PASS
AX-2025-019088Thymosin α1GSPGSP-2501-J2797Nordanalyt2025-Q298.583.50—Buyer-sourced0PASS
AX-2025-018913CJC-1295 with DACTFSTFS-{CAT}-1220Janoshik2025-Q298.244.0799.7Laboratory-retained1MARGINAL
AX-2025-018811ExenatideFGPFGP-2504-V8032Janoshik2025-Q298.984.3290.6Buyer-sourced0PASS
AX-2025-021159IpamorelinPPGPPG-2505-U7155Kestrel2025-Q299.934.59—Laboratory-retained0PASS
AX-2025-021056TirzepatideBCHBCH-2501-D4197VendorInvestigate2025-Q296.884.95—Buyer-sourced0FAIL
AX-2025-020780SelankCPCCPC-2504-F9844PeptideMeter2025-Q298.909.18—Buyer-sourced0FAIL
AX-2025-020761TirzepatideSGNSGN-2503-P9641VendorInvestigate2025-Q297.143.60—Buyer-sourced1MARGINAL
AX-2025-020705MGFSGNSGN-2503-S9261PeptideMeter2025-Q299.353.1892.6Buyer-sourced0PASS
AX-2025-020624MK-677 (Ibutamoren mesylate)GL BiochemGLBI-2501-Y7989Janoshik2025-Q298.694.68—Buyer-sourced1FAIL
AX-2025-020394TirzepatideMKMMKM-2411-B3993Nordanalyt2025-Q298.495.12—Buyer-sourced0PASS
AX-2025-020207OxytocinERPERP-2503-A9615VendorInvestigate2025-Q299.024.5993.3Buyer-sourced0PASS
AX-2025-019984TirzepatideHJHJ-2505-H6642Janoshik2025-Q298.675.34—Buyer-sourced0PASS
AX-2025-019882MK-677 (Ibutamoren mesylate)HJHJ-2501-G5680Kestrel2025-Q299.935.42—Buyer-sourced0FAIL
AX-2025-019818SemaglutideHomopeptideHOMO-2501-A5192Medutest2025-Q299.935.5992.8Buyer-sourced0PASS
AX-2025-019110RetatrutideGSPGSP-2411-B2857Janoshik2025-Q297.736.55—Buyer-sourced0PASS
AX-2025-019106RetatrutideGSPGSP-2411-B2857Janoshik2025-Q297.587.19104.1Buyer-sourced0PASS
AX-2025-018968TirzepatideASYASY-{CAT}-1787Janoshik2025-Q298.443.34—Buyer-sourced0PASS
AX-2025-018806ExenatideFGPFGP-2504-V8032VendorInvestigate2025-Q298.523.76105.3Buyer-sourced0PASS
AX-2025-018782GHRP-6FGPFGP-2411-J8288Janoshik2025-Q299.666.69—Buyer-sourced0PASS
AX-2025-021152IpamorelinPPGPPG-2505-U7155Kestrel2025-Q299.934.60103.9Buyer-sourced0PASS
AX-2025-020251IpamorelinGGPepsGGPE-2411-B1929Medutest2025-Q299.384.7798.4Buyer-sourced1FAIL
AX-2025-019523GHRP-6JEEPJEEP-2503-B8635Janoshik2025-Q299.544.94—Buyer-sourced0PASS
AX-2025-018814ExenatideFGPFGP-2504-V8032PeptideMeter2025-Q298.433.69—Buyer-sourced0PASS
AX-2025-021193RetatrutidePPGPPG-2501-B7212VendorInvestigate2025-Q299.253.48104.3Buyer-sourced0PASS
AX-2025-020784SelankCPCCPC-2504-F9844Janoshik2025-Q298.959.26—Buyer-sourced0FAIL
AX-2025-020734TriptorelinSGNSGN-2504-A9334Medutest2025-Q298.814.98103.8Buyer-sourced0PASS